Prescribing Information Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases. NON-CONTRACEPTIVE HEALTH BENEFITS The following non-contraceptive health benefits related to the use of combination oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing estrogen doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg mestranol. 73-78 Effects on menses: ° increased menstrual cycle regularity ° decreased blood loss and decreased incidence of iron deficiency anemia ° decreased incidence of dysmenorrhea Effects related to inhibition of ovulation: ° decreased incidence of functional ovarian cysts ° decreased incidence of ectopic pregnancies Other effects: ° decreased incidence of fibroadenomas and fibrocystic disease of the breast ° decreased incidence of acute pelvic inflammatory disease ° decreased incidence of endometrial cancer ° decreased incidence of ovarian cancer | ||||
Email this article
Printer friendly
Bookmark this pageadvertisement
